United States HRES 1285: Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Status: Submitted in House (as of 2026-05-14)

State: United States · Session: 119 · Bill: HRES 1285

Sponsors: Ayanna Pressley, Jennifer L. McClellan, Katherine M. Clark, Wesley Bell, Paul Tonko, Jesús G. "Chuy" García, Nydia M. Velázquez, Seth Moulton, Brittany Pettersen, Eleanor Holmes Norton, Becca Balint, Maxine Dexter, Suzan K. DelBene, Greg Stanton, Bill Foster, Lateefah Simon, Ritchie Torres, Christopher R. Deluzio, Jasmine Crockett, Julie Johnson, Kathy Castor, Gwen Moore, Gregory W. Meeks, Jonathan L. Jackson, Janice D. Schakowsky

View United States HRES 1285 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.